Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. Its technologies allow creating humanized antibodies that can be used either alone in unlabeled or naked form or conjugated with radioactive isotopes, chemotherapeutics, cytokines, or toxins.
|HQ||Morris Plains, US||Map|
Gross profit (Q2, 2020)
Gross profit margin (Q2, 2020), %
Net income (Q2, 2020)
EBIT (Q2, 2020)
Market capitalization (17-Sept-2020)
Closing stock price (17-Sept-2020)
|Company Name||Date||Deal Size|
|IBC Pharmaceuticals, Inc.|
When was Immunomedics founded?
Immunomedics was founded in 1982.
Who are Immunomedics key executives?
Immunomedics's key executives are Behzad Aghazadeh, Usama Malik and Brendan Delaney.
How many employees does Immunomedics have?
Immunomedics has 366 employees.
What is Immunomedics revenue?
Latest Immunomedics annual revenue is $295 k.
What is Immunomedics revenue per employee?
Latest Immunomedics revenue per employee is $806 .
Who are Immunomedics competitors?
Competitors of Immunomedics include Novartis, ImmunoGen and AstraZeneca.
Where is Immunomedics headquarters?
Immunomedics headquarters is located at 300 The American Rd, Morris Plains.
Where are Immunomedics offices?
Immunomedics has offices in Morris Plains and Rödermark.
How many offices does Immunomedics have?
Immunomedics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies